$110,000 of INCYTE CORPORATION lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues relating to CMS coverage and reimbursement policies."
You can find more data on corporate lobbying on Quiver Quantitative.
INCY Insider Trading Activity
INCY insiders have traded $INCY stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $INCY stock by insiders over the last 6 months:
- PABLO J CAGNONI (President, Global Head of R&D) has made 0 purchases and 3 sales selling 56,002 shares for an estimated $5,444,331.
- STEVEN H STEIN (CMO & Head of Late-Stage Dev.) sold 28,237 shares for an estimated $3,192,192
- THOMAS TRAY (Principal Accounting Officer) has made 0 purchases and 2 sales selling 4,690 shares for an estimated $463,564.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
INCY Hedge Fund Activity
We have seen 376 institutional investors add shares of INCY stock to their portfolio, and 353 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 2,526,758 shares (+341.7%) to their portfolio in Q1 2026, for an estimated $237,818,462
- GOLDMAN SACHS GROUP INC added 1,067,757 shares (+83.2%) to their portfolio in Q1 2026, for an estimated $100,497,288
- DODGE & COX removed 1,009,386 shares (-7.6%) from their portfolio in Q1 2026, for an estimated $95,003,410
- AQR CAPITAL MANAGEMENT LLC removed 912,094 shares (-13.6%) from their portfolio in Q1 2026, for an estimated $85,846,287
- SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) removed 754,116 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $70,977,397
- BLACKROCK, INC. added 650,275 shares (+3.5%) to their portfolio in Q1 2026, for an estimated $61,203,883
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 566,339 shares (-24.8%) from their portfolio in Q1 2026, for an estimated $53,303,826
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
INCY Analyst Ratings
Wall Street analysts have issued reports on $INCY in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 06/29/2026
To track analyst ratings and price targets for INCY, check out Quiver Quantitative's $INCY forecast page.
INCY Price Targets
Multiple analysts have issued price targets for $INCY recently. We have seen 13 analysts offer price targets for $INCY in the last 6 months, with a median target of $105.0.
Here are some recent targets:
- Brian Abrahams from RBC Capital set a target price of $99.0 on 07/07/2026
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $140.0 on 06/29/2026
- Ashwani Verma from UBS set a target price of $113.0 on 06/26/2026
- Evan Seigerman from BMO Capital set a target price of $94.0 on 06/22/2026
- Srikripa Devarakonda from Truist Securities set a target price of $105.0 on 06/22/2026
- Jeffrey Walch from Bernstein set a target price of $99.0 on 05/22/2026
- Stephen Willey from Stifel set a target price of $123.0 on 04/29/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
